Gender differences in symptoms in partial responders to proton pump inhibitors for gastro-oesophageal reflux disease

United European Gastroenterology Journal

Volumn 3, Issue 5, 2015, Pages 443-452

  Vakil, N ^a   Niklasson, A ^b   Denison, H ^b   Ryden A ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Abdominal pain; extra oesophageal symptoms; gastro oesophageal reflux disease; gender differences; heartburn

Indexed keywords

ANTIDEPRESSANT AGENT; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ADULT; ANXIETY DISORDER; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); CONSTIPATION; COUGHING; DEPRESSION; DIARRHEA; DYSPHAGIA; ERUCTATION; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM RATING SCALE; HEARTBURN; HOARSENESS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INDIGESTION; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; REFLUX SYMPTOM QUESTIONNAIRE; SEX DIFFERENCE; TREATMENT RESPONSE;

EID: 85006189471     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640614558343     Document Type: Article

References (33)

1. H.El-SeragA.BecherR.Jones. Systematic review: Persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther2010; 32: 720–737.
2. A.RuigomezS.JohanssonB.Wernersson. Gastroesophageal reflux disease in primary care: Using changes in proton pump inhibitor therapy as an indicator of partial response. Scand J Gastroenterol2012; 47: 751–761.
3. R.C.HeadingH.MonnikesA.Tholen. Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: A prospective pragmatic trial using pantoprazole. BMC Gastroenterol2011; 11: 52–52.
4. P.BytzerS.V.van ZantenH.Mattsson. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients. Aliment Pharmacol Ther2012; 36: 635–643.
5. J.LabenzD.ArmstrongS.Zetterstrand. Clinical trial: Factors associated with resolution of heartburn in patients with reflux oesophagitis–results from the EXPO study. Aliment Pharmacol Ther2009; 29: 959–966.
6. I.MizyedS.S.FassR.Fass. Review article: Gastro-oesophageal reflux disease and psychological comorbidity. Aliment Pharmacol Ther2009; 29: 351–358.
7. A.BecherH.El-Serag. Systematic review: The association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther2011; 34: 618–627.
8. F.ZerbibK.BelhocineM.Simon. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease. Gut2012; 61: 501–506.
9. I.WiklundR.CarlssonJ.Carlsson. Psychological factors as a predictor of treatment response in patients with heartburn: A pooled analysis of clinical trials. Scand J Gastroenterol2006; 41: 288–293.
10. J.M.PiquéK.R.KulichO.Vegazoc. Burden of gastroesophageal reflux disease. Evidence from a recent methodological study in Spain. Gastroenterol Hepatol2004; 27: 300–306.
11. A.MadischK.R.KulichP.Malfertheiner. Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany. Z Gastroenterol2003; 41: 1137–1143.
12. J.RegulaK.R.KulichJ.Stasiewicz. Burden of illness in patients with reflux disease – evidence from a recent methodological study in Poland. Przeglad Epidemiologiczny2005; 59: 75–85.
13. D.R.De VriesM.A.Van HerwaardenA.Baron. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease. Scand J Gastroenterol2007; 42: 951–956.
14. S.SeedatK.M.ScottM.C.Angermeyer. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry2009; 66: 785–795.
15. R.M.LovellA.C.Ford. Effect of gender on prevalence of irritable bowel syndrome in the community: Systematic review and meta-analysis. Am J Gastroenterol2012; 107: 991–1000.
16. N.B.VakilA.NiklassonH.Denison. Symptom pattern in gastroesophageal reflux disease: Comparison with treatment-naïve patients suggests overlapping disease entities in partial responders to proton pump inhibitor therapy. Gastroenterology2012; 142: S589–S590.
17. N.VakilK.BjörckH.Denison. Validation of the Reflux Symptom Questionnaire electronic diary in partial responders to proton pump inhibitor therapy. Clin Trans Gastroenterol2012; 3: e7–e7.
18. A.RydenH.DenisonM.Karlsson. Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors. Scand J Gastroenterol2013; 48: 1018–1026.
19. E.DimenäsH.GliseB.Hallerbäck. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol1995; 30: 1046–1052.
20. J.TackN.J.TalleyM.Camilleri. Functional gastroduodenal disorders. Gastroenterology2006; 130: 1466–1479.
21. A.S.ZigmondR.P.Snaith. The hospital anxiety and depression scale. Acta Psychiatr Scand1983; 67: 361–370.
22. P.J.KahrilasA.JonssonH.Denison. Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol2012; 10: 612–619.
23. P.J.KahrilasC.W.HowdenN.Hughes. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Am J Gastroenterol2011; 106: 1419–1425.
24. R.FassB.D.NaliboffS.S.Fass. The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. Gastroenterology2008; 134: 696–705.
25. B.NojkovJ.H.RubensteinS.A.Adlis. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther2008; 27: 473–482.
26. H.MonnikesR.C.HeadingH.Schmitt. Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease. World J Gastroenterol2011; 17: 3235–3241.
27. G.J.HemminkA.J.BredenoordB.L.Weusten. Supragastric belching in patients with reflux symptoms. Am J Gastroenterol2009; 104: 1992–1997.
28. Kessing BF, Bredenoord AJ, Velosa M, et al. Supragastric belches are the main determinants of troublesome belching symptoms in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2012; 35: 1073–1079
29. B.F.KessingA.J.BredenoordM.Velosa. Liquid-containing reflux events are more likely to be perceived as a belch than as heartburn or regurgitation. Gut2011; 60: P0247–P0247.
30. D.JaspersenM.KuligJ.Labenz. Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: An analysis based on the ProGERD Study. Aliment Pharmacol Ther2003; 17: 1515–1520.
31. K.Dal-PazJ.P.Moraes-FilhoT.Navarro-Rodriguez. Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease. Dis Esophagus2012; 25: 107–113.
32. J.RonkainenP.AroT.Storskrubb. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report. Scand J Gastroenterol2005; 40: 275–285.
33. R.M.ZagariL.FuccioM.A.Wallander. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: Loiano-Monghidoro study. Gut2008; 57: 1354–1359.